Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aspartyl Adenylate
1. 19046-78-7
2. Aspartyl Adenylate
3. Succinyl Amp
4. Adenylosuccinate
5. X1b4zj0iiv
6. Succinyladenosine 5'-monophosphate
7. N6-(1,2-dicarboxyethyl)-amp
8. L-aspartic Acid, N-[9-(5-o-phosphono-beta-d-ribofuranosyl)-9h-purin-6-yl]-
9. 2-[9-(3,4-dihydroxy-5-phosphonooxymethyl-tetrahydro-furan-2-yl)-9h-purin-6-ylamino]-succinic Acid
10. Succinyladenosine Monophosphoric Acid
11. L-aspartic Acid, N-(9-(5-o-phosphono-beta-d-ribofuranosyl)-9h-purin-6-yl)-
12. N(6)-(1,2-dicarboxyethyl)amp
13. 2sa
14. Adenyl-succinic Acid
15. 6-succino-5'-adenylate
16. Unii-x1b4zj0iiv
17. 6-succino-5'-adenylic Acid
18. Schembl198136
19. N6-(1,2-dicarboxyethyl)amp
20. Succinyladenosine Monophosphorate
21. Dtxsid80864869
22. L-aspartic Acid, N-(9-(5-o-phosphono-.beta.-d-ribofuranosyl)-9h-purin-6-yl)-
23. D-ribofuranosyl)-9h-purin-6-yl]
24. Zinc4096207
25. Adenylosuccinic Acid, ~96% (hplc)
26. Db04418
27. (2s)-2-[[9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic Acid
28. Hy-127137
29. Cs-0093525
30. C03794
31. Q27095207
32. D-ribofuranosyl-9h-purin-6-yl) Mono(dihydrogen Phosphate) (ester)
33. N-(9-(5-o-phosphono-.beta.-d-ribofuranosyl)-9h-purin-6-yl)-l-aspartic Acid
34. (2s)-2-[(9-{(2r,3r,4s,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydrofuran-2-yl}-9h-purin-6-yl)amino]butanedioic Acid (non-preferred Name)
35. (2s)-2-[[9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(phosphonooxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]butanedioic Acid
36. (s)-2-((9-((2r,3r,4s,5r)-3,4-dihydroxy-5-((phosphonooxy)methyl)tetrahydrofuran-2-yl)-9h-purin-6-yl)amino)succinic Acid
37. (s)-2-((9-((2r,3r,4s,5r)-3,4-dihydroxy-5-((phosphonooxy)methyl)tetrahydrofuran-2-yl)-9h-purin-6-yl)amino)succinicacid
38. (s)-2-(9-((2r,3r,4s,5r)-3,4-dihydroxy-5-(phosphonooxymethyl)tetrahydrofuran-2-yl)-9h-purin-6-ylamino)succinic Acid
| Molecular Weight | 463.29 g/mol |
|---|---|
| Molecular Formula | C14H18N5O11P |
| XLogP3 | -3.2 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 9 |
| Exact Mass | 463.07404340 g/mol |
| Monoisotopic Mass | 463.07404340 g/mol |
| Topological Polar Surface Area | 247 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 725 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Aspartyl Adenylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aspartyl Adenylate, including repackagers and relabelers. The FDA regulates Aspartyl Adenylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aspartyl Adenylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aspartyl Adenylate supplier is an individual or a company that provides Aspartyl Adenylate active pharmaceutical ingredient (API) or Aspartyl Adenylate finished formulations upon request. The Aspartyl Adenylate suppliers may include Aspartyl Adenylate API manufacturers, exporters, distributors and traders.
click here to find a list of Aspartyl Adenylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aspartyl Adenylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Aspartyl Adenylate active pharmaceutical ingredient (API) in detail. Different forms of Aspartyl Adenylate DMFs exist exist since differing nations have different regulations, such as Aspartyl Adenylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aspartyl Adenylate DMF submitted to regulatory agencies in the US is known as a USDMF. Aspartyl Adenylate USDMF includes data on Aspartyl Adenylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aspartyl Adenylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aspartyl Adenylate suppliers with USDMF on PharmaCompass.
Aspartyl Adenylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aspartyl Adenylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aspartyl Adenylate GMP manufacturer or Aspartyl Adenylate GMP API supplier for your needs.
A Aspartyl Adenylate CoA (Certificate of Analysis) is a formal document that attests to Aspartyl Adenylate's compliance with Aspartyl Adenylate specifications and serves as a tool for batch-level quality control.
Aspartyl Adenylate CoA mostly includes findings from lab analyses of a specific batch. For each Aspartyl Adenylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aspartyl Adenylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Aspartyl Adenylate EP), Aspartyl Adenylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aspartyl Adenylate USP).
LOOKING FOR A SUPPLIER?
